This report is useful for M&A, business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory firms and corporates to decide upon their investment strategies. Do connect with us, if you are looking for equity valuation, recommendation, analysis and market recommendation for any specific company, sector and industry.

Protein engineering has seen AI design novel proteins such as esmGFP(Artificial green fluorescent protein designed using the AI model
ESM3, developed by Evolutionary Scale), while explainable AI models improve CRISPR genome-editing safety and efficiency.

 In drug discovery, machine learning accelerates target identification, molecule design, and repurposing, with companies like Recursion and Insilico advancing AI-generated drug candidates into clinical trials.

The global AI in biotech market is projected to grow from $4.7bn in 2024 to nearly $13.55bn by 2030, at a CAGR of 19.26%.

 AI Applications in Biotech
• Technologies Enabling AI in Biotech
• Key Players

―Royalty Pharma Inc

―ADMA Biologics Inc

―Regeneron Pharmaceuticals, Inc

―Amgen Inc

―Biogen Inc

―Twist Bioscience Corp

―United Therapeutics

Challenges
• CrispIdea Outlook

• Company Reports

―Royalty Pharma Inc

―ADMA Biologics Inc

―Regeneron Pharmaceuticals, Inc

―Amgen Inc

―Biogen Inc

―Twist Bioscience Corp

―United Therapeutics

This report was produced by a member company of the Crispidea. This report is for the use of intended recipients only and may not be reproduced (in whole or in part) or delivered or transmitted to any other person without our prior written consent. By accepting this report, the recipient agrees to be bound by the terms and limitations set out herein.

https://www.crispidea.com/report-category/sector-research-reports-industry/